Skip to content

Surgical treatment for thumb arthritis: trapeziectomy vs trapeziometacarpal arthrodesis

Randomized clinical trial - surgical treatment of rhizarthrosis: trapeziectomy vs. trapeziometacarpal arthrodesis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4jpxy84
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhizarthrosis

Interventions

This is a two-arm randomized controlled clinical trial. The two groups will each consist of 42 patients with stage II or III rhizarthrosis. Group 1 will receive trapeziectomy with suspensory plasty an
C05.550

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteers diagnosed with rhizarthrosis in stages II and III of the Eaton and Littler classification; age over 40 years

Exclusion criteria

Exclusion criteria: Previous surgical treatment for rhizarthrosis; rhizarthrosis in stage IV of the Eaton and Littler classification; tendon injury or fractures of the metacarpals or phalanges that generate functional limitation; previous surgical treatment for the carpal bones; contraindication to the anesthetic procedure

Design outcomes

Primary

MeasureTime frame
To evaluate the functional outcome using the TASD (Symptoms and Disability of Trapeziometacarpal Osteoarthritis) functionality questionnaire, which consists of a questionnaire with a maximum functionality score of 100, with the aim of evaluating the differences in functionality scores between the groups;To assess functional outcome using the QuickDASH (Disabilitys of the Arm, Shoulder and Hand) functionality questionnaire, which consists of a questionnaire with a maximum functionality score of 100

Secondary

MeasureTime frame
Trapeziometacarpal joint pain will be assessed using the Visual Analogue Pain Scale (VAS). This is a unidimensional measure of pain intensity that has been widely used in various adult populations. The VAS pain scale is a continuous scale consisting of a 10-cm-long horizontal line anchored by two verbal descriptors: one for each extreme symptom (no pain, with a score of 0) and the worst imaginable pain, with a score of 100);Handgrip strength will be measured using a Jamar dynamometer. The assessment follows the American Hand Therapists Society protocol, with the patient seated, feet supported, elbow at 90 degrees, shoulder adducted, and forearm and wrist in neutral. Three measurements are taken of each upper limb, with a rest of ten seconds to one minute between each measurement. The final result is calculated by averaging the three measurements;Pinch strength, which will be assessed by a finger dynamometer, is used. To assess the pulp-to-pulp and three-point pinch, the forearm is held pronated. Three measurements will be taken with each upper limb for each type of pinch, and the average of these three measurements will be calculated;Opposition degree, which will be assessed using the Kapandji Index, which consists of a ten-point scale that objectively measures the functional opposition movement of the thumb. It has significant clinical implications, since a large proportion of hand function depends on this thumb movement. The score ranges from zero, when there is no movement or when the thumb pad reaches the lateral aspect of the proximal phalanx of the index finger, to 10 when the thumb pad reaches the distal palmar crease at the ulnar border;Operative failure, which will be confirmed when it is verified, at any time postoperatively, the maintenance of persistent pain, located in the topography of the trapeziometacarpal joint or other complications that require an additional surgical procedure and/or hospital admission after discharge, will be considered treatment

Countries

Brazil

Contacts

Public ContactJoão Belloti

Universidade Federal de São Paulo

jcbelloti@gmail.com+55(11)91165-3111

Outcome results

None listed

Source: REBEC (via WHO ICTRP)